Peer-reviewedCC BY-NC-NDCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
La présence de médétomidine sur le marché des drogues illicites.
- 1Service de médecine d'urgence (Miles), Providence Health Care; Département de médecine d'urgence (Miles), University of British Columbia, Vancouver, C.-B.; Département de médecine d'urgence (Koh), Queen's University, Kingston, Ont.; Département de médecine (Bach), University of British Columbia; British Columbia Centre on Substance Use (Bach), St. Paul's Hospital, Vancouver, C.-B.
Related
- State xylazine scheduling and changes in xylazine and medetomidine reports in the U.S. illicit drug supply: A quasi-experimental study
- Characterizing the Emergence of Medetomidine in Southern California Fentanyl Markets
- Effects of an Intensive Gait Training Rehabilitation Protocol After Single Event Multilevel Surgery in Cerebral Palsy: Activ'Marche.
- Physicochemical properties of native and extruded maize flours in the presence of animal proteins
- FDA Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites: Testing Presence, Prominence, and Wording
BibTeX
@article{miles2026présence,
title = {{La présence de médétomidine sur le marché des drogues illicites.}},
author = {Isabelle Miles and Justin J Koh and Paxton Bach},
journal = {CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne},
year = {2026},
month = oct,
doi = {10.1503/cmaj.260399-f},
url = {https://europepmc.org/article/MED/42896876},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - La présence de médétomidine sur le marché des drogues illicites.
AU - Isabelle Miles
AU - Justin J Koh
AU - Paxton Bach
PY - 2026
DA - 2026/10/18
JO - CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
DO - 10.1503/cmaj.260399-f
UR - https://europepmc.org/article/MED/42896876
SN - 0820-3946
SN - 1488-2329
ER -